BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 30975729)

  • 1. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonatrial Fibrillation was Associated With Early Neurological Improvement After Intravenous Thrombolysis With rt-PA in Patients With Acute Ischemic Stroke.
    Liu J; Huang J; Xu H; Dai H
    Neurologist; 2020 Mar; 25(2):28-32. PubMed ID: 32132497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of functional outcome in patients with stroke thrombolysis in a tertiary hospital in Malaysia.
    Tai MLS; Goh KJ; Kadir KAA; Zakaria MI; Yap JF; Tan KS
    Singapore Med J; 2019 May; 60(5):236-240. PubMed ID: 30488077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke.
    Kharitonova T; Mikulik R; Roine RO; Soinne L; Ahmed N; Wahlgren N;
    Stroke; 2011 Jun; 42(6):1638-43. PubMed ID: 21512176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early neurologic improvement based on the National Institutes of Health Stroke Scale score predicts favorable outcome within 30 minutes after undergoing intravenous recombinant tissue plasminogen activator therapy.
    Takagi T; Kato T; Sakai H; Nishimura Y
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):69-74. PubMed ID: 23164483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly improving stroke symptoms: a pilot, prospective study.
    Balucani C; Bianchi R; Ramkishun C; Weedon J; Law S; Szarek M; Rojas-Soto D; Tariq S; Levine SR
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1211-6. PubMed ID: 25869774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimode Computed-Tomography-Guided Thrombolysis under a Prolonged Time Window in Acute Ischemic Stroke Patients with Atrial Fibrillation.
    Yang Y; Sun W; Li D; Li XY; Wang XT; Li SC; Zhao HJ; Zhang JB
    Int Heart J; 2019 Jul; 60(4):822-829. PubMed ID: 31257338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NIHSS cut point for predicting outcome in supra- vs infratentorial acute ischemic stroke.
    Yoshimura S; Lindley RI; Carcel C; Sato S; Delcourt C; Wang X; Chalmers J; Anderson CS;
    Neurology; 2018 Oct; 91(18):e1695-e1701. PubMed ID: 30266885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redefining Early Neurological Improvement After Reperfusion Therapy in Stroke.
    Agarwal S; Cutting S; Grory BM; Burton T; Jayaraman M; McTaggart R; Reznik M; Scher E; Chang AD; Frontera J; Lord A; Rostanski S; Ishida K; Torres J; Furie K; Yaghi S
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104526. PubMed ID: 31836356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous thrombolytic therapy for acute anterior ischemic stroke: Experience at the French Military Teaching Hospital in Toulon from 2003 to 2014.
    Sahuc-Rodrigues P; Sagui E; Wybrecht D; Veyrières JB; Gazzola S; Dagain A; Valance J; Alla P; Faivre A
    Rev Neurol (Paris); 2018 Mar; 174(3):125-136. PubMed ID: 29128152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild stroke: safety and outcome in patients receiving thrombolysis.
    Logallo N; Kvistad CE; Naess H; Waje-Andreassen U; Thomassen L
    Acta Neurol Scand Suppl; 2014; (198):37-40. PubMed ID: 24588505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma HMGB1 in ischemic stroke patients with cerebral ischemia-reperfusion injury after intravenous thrombolysis.
    Wang J; Jiang Y; Zeng D; Zhou W; Hong X
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105055. PubMed ID: 32807461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen Activator.
    Betts KA; Hurley D; Song J; Sajeev G; Guo J; Du EX; Paschoalin M; Wu EQ
    J Stroke Cerebrovasc Dis; 2017 Sep; 26(9):1996-2003. PubMed ID: 28689999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based ultrafast protocol thrombolysis with rt-PA for acute ischemia stroke in 12-hour time window.
    Li YH; Li MH; Zhao JG; Wang W
    J Neuroimaging; 2011 Oct; 21(4):332-9. PubMed ID: 21121996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.